Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
IntraFuse is a medical device company specializing in the development of minimally invasive orthopedic implants for fracture fixation and joint fusion. The company's flagship technology, the IntraFuse System, utilizes a percutaneous, intramedullary approach to provide stable internal fixation for small bone procedures, particularly in the foot and ankle. By minimizing soft tissue disruption and providing robust mechanical stability, IntraFuse's products aim to accelerate healing times and improve patient outcomes compared to traditional open surgical methods. The company focuses on addressing common podiatric and orthopedic conditions such as hammertoe deformities and metatarsal fractures.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on IntraFuse.